CA2342585A1 - A new composition - Google Patents

A new composition Download PDF

Info

Publication number
CA2342585A1
CA2342585A1 CA002342585A CA2342585A CA2342585A1 CA 2342585 A1 CA2342585 A1 CA 2342585A1 CA 002342585 A CA002342585 A CA 002342585A CA 2342585 A CA2342585 A CA 2342585A CA 2342585 A1 CA2342585 A1 CA 2342585A1
Authority
CA
Canada
Prior art keywords
treatment
component
pharmaceutical formulation
composition
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342585A
Other languages
English (en)
French (fr)
Inventor
John Evenden
Seth-Olov Thorberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342585A1 publication Critical patent/CA2342585A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002342585A 1998-09-16 1999-09-13 A new composition Abandoned CA2342585A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition
SE9803157-8 1998-09-16
PCT/SE1999/001598 WO2000015219A1 (en) 1998-09-16 1999-09-13 A new composition

Publications (1)

Publication Number Publication Date
CA2342585A1 true CA2342585A1 (en) 2000-03-23

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342585A Abandoned CA2342585A1 (en) 1998-09-16 1999-09-13 A new composition

Country Status (21)

Country Link
EP (1) EP1121119A1 (hu)
JP (1) JP2002524509A (hu)
KR (1) KR20010099648A (hu)
CN (1) CN1317963A (hu)
AR (1) AR023657A1 (hu)
AU (1) AU6378199A (hu)
BR (1) BR9913765A (hu)
CA (1) CA2342585A1 (hu)
CZ (1) CZ2001962A3 (hu)
EE (1) EE200100156A (hu)
HU (1) HUP0103569A3 (hu)
ID (1) ID28359A (hu)
IL (1) IL141520A0 (hu)
IS (1) IS5877A (hu)
NO (1) NO20011313L (hu)
PL (1) PL346769A1 (hu)
SE (1) SE9803157D0 (hu)
SK (1) SK3272001A3 (hu)
TR (1) TR200100769T2 (hu)
WO (1) WO2000015219A1 (hu)
ZA (1) ZA200101951B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
CA2425638C (en) 2000-10-13 2011-04-05 Neurosearch A/S Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
WO2006123243A2 (en) 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
ZA200101951B (en) 2002-06-10
PL346769A1 (en) 2002-02-25
SK3272001A3 (en) 2001-09-11
HUP0103569A2 (hu) 2002-02-28
EP1121119A1 (en) 2001-08-08
AR023657A1 (es) 2002-09-04
ID28359A (id) 2001-05-17
HUP0103569A3 (en) 2002-03-28
AU6378199A (en) 2000-04-03
SE9803157D0 (sv) 1998-09-16
NO20011313D0 (no) 2001-03-15
IS5877A (is) 2001-03-05
KR20010099648A (ko) 2001-11-09
NO20011313L (no) 2001-05-16
BR9913765A (pt) 2001-06-05
TR200100769T2 (tr) 2001-11-21
IL141520A0 (en) 2002-03-10
CZ2001962A3 (cs) 2001-08-15
CN1317963A (zh) 2001-10-17
EE200100156A (et) 2002-08-15
WO2000015219A1 (en) 2000-03-23
JP2002524509A (ja) 2002-08-06

Similar Documents

Publication Publication Date Title
US6184218B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
US20090306137A1 (en) Treatment for depressive disorders
JP4571485B2 (ja) D4および5−ht2aアンタゴニスト、逆アゴニストまたは部分アゴニストの使用
BRPI0713733A2 (pt) métodos para diminuir os sintomas de depressão e para tratar uma ou mais condições psicológicas, composição farmacêutica e kit
US6472423B1 (en) Pharmaceutical composition
CA2342585A1 (en) A new composition
WO2017041112A1 (en) Ketamine and cytochrome p 450 inhibitor combinations
CA2342233A1 (en) A new composition
CA2342223A1 (en) A new composition
CA2342341A1 (en) A new composition
JP4571645B2 (ja) D4および5−ht2aアンタゴニスト、逆アゴニストまたは部分アゴニストの使用
MXPA01002543A (en) A new composition
KR20060124639A (ko) 세로토닌 재흡수 억제제 및 히스타민 3 수용체안타고니스트, 역 아고니스트 또는 부분 아고니스트의 조합
JP2002532548A (ja) いびきおよび解剖学的上気道の高抵抗症候群を治療するための薬剤を製造するための5ht2aおよび5ht2a/c受容体アンタゴニストの使用
MXPA01002370A (en) A new composition
JP2008303146A (ja) 睡眠障害予防治療剤
JP2008255058A (ja) 睡眠障害予防治療剤

Legal Events

Date Code Title Description
FZDE Discontinued